Skip to main content
Celyad Oncology SA logo

Celyad Oncology SA — Investor Relations & Filings

Ticker · CYAD ISIN · BE0974260896 LEI · 549300ORR0M8XF56OI64 BR Professional, scientific and technical activities
Filings indexed 923 across all filing types
Latest filing 2024-09-15 Interim / Quarterly Rep…
Country BE Belgium
Listing BR CYAD

About Celyad Oncology SA

https://celyad.com/

Celyad Oncology is a biotechnology company primarily focused on unlocking the potential of its intellectual property in the field of cell therapy. The company discovers and develops innovative technologies for Chimeric Antigen Receptor T-cell (CAR-T) therapies aimed at treating cancer. Its differentiated strategy includes the advancement of proprietary technology platforms and CAR T-cell candidates designed to broaden the range of treatable cancer indications and overcome the main limitations of existing CAR T-cell therapies.

Recent filings

Filing Released Lang Actions
Celyad Oncology - RAPPORT FINANCIER INTERMEDIAIRE_2024 - FR.pdf
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'RAPPORT FINANCIER INTERMEDIAIRE' (Interim Financial Report) for the first semester of 2024. It contains comprehensive financial statements, management commentary, and notes to the financial statements, which aligns perfectly with the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report, but the report itself. H1 2024
2024-09-15 French
AGEx Ceyad Oncology 6 mai 2024 - signatures digitales.pdf
AGM Information Classification · 99% confidence The document is a formal notarial record ('procès-verbal') detailing the proceedings and resolutions of an 'ASSEMBLEE GENERALE EXTRAORDINAIRE' (Extraordinary General Meeting) of the company 'Celyad Oncology'. The key agenda items involve a 'REDUCTION DU COMPTE "PRIMES D'EMISSION" ET DU CAPITAL PAR APUREMENT DES PERTES' (Reduction of the 'Share Premium' account and capital by writing off losses) and subsequent modification of the statutes. This type of official record documenting shareholder decisions, especially those involving capital structure changes and statutory amendments made during a general meeting, strongly aligns with the purpose of an Annual General Meeting (AGM) or an Extraordinary General Meeting (EGM) record. Since the document details the resolutions passed and the voting results within the meeting context, the most appropriate classification is AGM-R (AGM Information/Record), as EGMs often follow similar documentation protocols to AGMs regarding formal resolutions and minutes.
2024-05-06 French
PV AGO Ceyad Oncology 6 mai 2024 - signé - FR.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROCES-VERBAL DE L'ASSEMBLEE GENERALE ORDINAIRE DES ACTIONNAIRES DU 6 MAI 2024" (Minutes of the Ordinary General Meeting of Shareholders of May 6, 2024). It details the composition of the meeting, the quorum achieved, the agenda items voted upon (including approval of annual accounts, remuneration reports, and director reappointments), and the final voting results. This content perfectly matches the definition of an Annual General Meeting record, which corresponds to the AGM-R filing code.
2024-05-06 French
CELYAD-AGO-et-AGE-mai-2024-Informations-aux-actionnaires-FR.Final_.pdf
AGM Information Classification · 98% confidence The document explicitly details the rights of shareholders concerning the upcoming Annual General Meeting (AGM) scheduled for May 6, 2024. Specifically, it outlines the procedures for shareholders to request items be added to the agenda (Article 7:130 of the Belgian Code of Companies and Associations) and the process for submitting written questions prior to the meeting. This content is directly related to the preparation and conduct of a general meeting, focusing on shareholder participation rights, which aligns perfectly with the definition of AGM Information (AGM-R). It is not a proxy statement (PSI) as it doesn't solicit votes, nor is it a declaration of voting results (DVA).
2024-04-05 French
Rapport_Special_CA_pour_AGE_Sonnette_dalarme_-_2024_-_FR.signed.pdf
Legal Proceedings Report Classification · 99% confidence The document is explicitly titled "RAPPORT SPECIAL DU CONSEIL D'ADMINISTRATION A L'ASSEMBLEE GENERALE DES ACTIONNAIRES EN ACCORD AVEC L'ARTICLE 7:228 DU CODE BELGE DES SOCIETES ET ASSOCIATIONS" (Special Report of the Board of Directors to the General Meeting of Shareholders in accordance with Article 7:228 of the Belgian Companies and Associations Code). This report addresses the situation where the net assets have fallen below 50% of the share capital, triggering the 'alarm bell' procedure, and proposes a resolution to the shareholders regarding the continuation of the company rather than dissolution. This type of mandatory report presented to shareholders for a vote concerning the company's continuity or dissolution, often linked to specific legal requirements surrounding general meetings, aligns best with the purpose of an Annual General Meeting (AGM) related document, even though it is a specific legal report rather than a standard presentation. Since it is a formal report presented to the shareholders for deliberation at a general meeting, AGM-R is the most appropriate classification, as it directly relates to the proceedings and required documentation for that meeting.
2024-04-05 French
Celyad-Oncology-coord.-ENG-06.05.2024.pdf
Governance Information Classification · 98% confidence The document is titled 'Coordinated Articles of Association of the société anonyme "Celyad Oncology"' and details the history of amendments to these articles, referencing official Belgian publications ('Moniteur Belge'). Articles of Association define the fundamental rules, structure, and governance of a corporation. This content directly relates to the company's internal rules and structure, which aligns best with the Governance Information category (CGR). It is not a financial report (10-K, IR), an earnings announcement (ER), or a proxy statement (PSI).
2024-04-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.